FDA backs Pfizer COVID-19 boosters for seniors, high-risk

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca